SUBSCRIBE
SUBSCRIBE

Phase II

Courtesy of Jer123/Getty Images
Drug Development
NIH Pushing Large-Scale, Organized COVID-19 Trials
Francis Collins, the director of the NIH, told STAT they were “really well-powered, rigorously designed clinical trials.”
July 23, 2020
 · 
4 min read
 · 
Mark Terry
Policy
Biopharma Update on the Novel Coronavirus: July 22
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 22, 2020.
July 21, 2020
 · 
6 min read
 · 
BioSpace Editorial Staff
Drug Development
CanSino’s Early Phase II COVID-19 Vaccine Data Shows Promise
CanSino Biologics, along with China’s military research unit, reported early data on its Phase II trial for its COVID-19 vaccine, Ad5-nCOV.
July 21, 2020
 · 
3 min read
 · 
Mark Terry
Policy
Biopharma Update on the Novel Coronavirus: July 20
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 20, 2020.
July 20, 2020
 · 
2 min read
 · 
BioSpace Editorial Staff
Drug Development
Clinical Catch-Up: July 13-17
It was a surprisingly big week for clinical trial updates related to COVID-19, although there was plenty of non-COVID-19 news as well. Here’s a look.
July 17, 2020
 · 
8 min read
 · 
Mark Terry
Policy
Biopharma Update on the Novel Coronavirus: July 17
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 17, 2020.
July 16, 2020
 · 
5 min read
 · 
BioSpace Editorial Staff
Drug Development
AC Immune’s Tau Vaccine for Alzheimer’s Advanced into Phase Ib/II Clinical Trials
AC Immune, based in Lausanne, Switzerland, initiated the second highest dosing group in its Phase Ib/IIa clinical trial of ACI-35.030 for Alzheimer’s disease. The move is based on encouraging interim data from the initial dosing cohort.
July 16, 2020
 · 
3 min read
 · 
Mark Terry
Business
NovoCure, Merck Team Up on Phase II Lung Cancer Trial
Together, the companies will develop Tumor Treating Fields with Merck’s anti-PD-1 therapy, Keytruda for the treatment of non-small cell lung cancer (NSCLC).
July 15, 2020
 · 
3 min read
 · 
Krystle Vermes
Policy
Biopharma Update on the Novel Coronavirus: July 15
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 15, 2020.
July 14, 2020
 · 
5 min read
 · 
BioSpace Editorial Staff
Drug Development
Biopharma Update on the Novel Coronavirus: July 13
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 13, 2020.
July 13, 2020
 · 
3 min read
 · 
BioSpace Editorial Staff
Load More
PRESS RELEASES
Drug Development
Osivax Announces Publication in The Lancet Infectious Diseases of Phase 2a Data for Broad-Spectrum Influenza Vaccine Candidate, OVX836
July 27, 2023
 · 
5 min read
Drug Development
Cullgen Announces First-In-Human Dose in Phase I/II Trial of CG001419, a First-in-Class TRK Protein Degrader for Treatment of Cancer Patients
July 27, 2023
 · 
2 min read
Drug Development
Corrected: Keros Therapeutics to Host Conference Call and Webcast to Provide an Overview of TROPOS, the KER-012 Phase 2 Clinical Trial in Patients with Pulmonary Arterial Hypertension
July 27, 2023
 · 
6 min read
Drug Development
Disc Medicine Announces First Patient Enrolled in Phase 1/2 Clinical Trial of Bitopertin in Diamond-Blackfan Anemia (DBA)
July 27, 2023
 · 
5 min read
Drug Development
Avenue Therapeutics Announces First Patient Dosed in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy’s Disease)Topline data expected in 2024
July 27, 2023
 · 
8 min read
Drug Development
Telavant, a Roivant Company, Advances Inflammatory Bowel Disease Program with First Patient Dosed in Global Phase 2 Trial of Novel Anti-TL1A Antibody RVT-3101 in Crohn’s Disease
July 27, 2023
 · 
7 min read
Business
ENHERTU® (fam-trastuzumab deruxtecan-nxki) Demonstrated Clinically Meaningful Progression-Free Survival and Overall Survival Across Multiple HER2-Expressing Advanced Solid Tumors in DESTINY-PanTumor02 Phase II Trial
July 27, 2023
 · 
26 min read
Drug Development
EyePoint Pharmaceuticals Presents Interim Masked Safety Data and Patient Baseline Characteristics for DAVIO 2 Clinical Trial at OIS Retina Innovation Summit
July 27, 2023
 · 
8 min read
Drug Development
LPCN 1148 Phase 2 Study Meets Primary Endpoint in Patients with Cirrhosis
July 27, 2023
 · 
11 min read
Drug Development
ENHERTU® Demonstrated Clinically Meaningful Progression-Free Survival and Overall Survival Across Multiple HER2 Expressing Advanced Solid Tumors in DESTINY-PanTumor02 Phase 2 Trial
July 27, 2023
 · 
26 min read
Drug Development
The New England Journal of Medicine Publishes Data from Phase 2 Study of First Oral Orexin Receptor 2 Agonist TAK-994 in Patients with Narcolepsy Type 1
July 26, 2023
 · 
10 min read
Drug Development
Tonix Pharmaceuticals Announces Accelerating Completion of Enrollment in Phase 2 UPLIFT Study of TNX-601 ER (Racemic Tianeptine) for Major Depressive Disorder: Topline Data Now Expected in Fourth Quarter 2023
July 26, 2023
 · 
20 min read
Drug Development
Organicell Reports Interim Results of Phase 1/2A Research Program
July 26, 2023
 · 
4 min read
Drug Development
Ocuphire to Present at American Society of Retina Specialists Annual Meeting and OIS Retina Innovation Summit
July 26, 2023
 · 
6 min read
Drug Development
Humacyte Completes Enrollment in Phase 2/3 Trial of Human Acellular Vessel™ (HAV™) for Vascular Trauma Repair
July 26, 2023
 · 
9 min read
Drug Development
Oryzon Announces Completed Patient Recruitment in the PORTICO Phase IIb Trial of vafidemstat in Borderline Personality Disorder
July 26, 2023
 · 
8 min read
Drug Development
Recce Pharmaceuticals Doses Subjects in Rapid Infusion Phase I/II UTI Clinical Trial of RECCE® 327 at Scientia Clinical Research
July 26, 2023
 · 
2 min read
Drug Development
Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned
July 26, 2023
 · 
6 min read
Drug Development
United States Food and Drug Administration (FDA) Authorizes Phase 2 Study of DB107 In Promising Turn-Around of Targeted Treatment to Treat Newly Diagnosed High Grade Glioma
July 25, 2023
 · 
6 min read
Drug Development
Mabwell to Present Clinical Trial Data of 2 Programs at ESMO Congress 2023
July 25, 2023
 · 
6 min read
Load More